IMC Chicago’s ResMed RMD Stock Holding History

IMC Chicago’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-16,977	Closed	-$3.79M	–	2997
2024 Q2	$3.25M	Buy	+16,977	New	+$3.44M	﹤0.01%	1286

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

IMC Chicago's RMD Position: Q3 2024 in Review

IMC Chicago sold out of ResMed (RMD) in Q3 2024, closing a stake of 16,977 shares — an estimated $3.79M sold.

IMC Chicago first reported a position in RMD in Q2 2024 and held it in 1 quarter. The position peaked at $3.25M in Q2 2024. 802 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

IMC Chicago reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
IMC Chicago sold 16,977 ResMed shares in Q3 2024, an estimated $3.79M.
IMC Chicago first reported a position in ResMed in Q2 2024 and held it in 1 quarter.
IMC Chicago's ResMed position peaked at $3.25M in Q2 2024.
802 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on IMC Chicago's 13F filing for Q3 2024, filed 25 Oct 2024.